MMEDF - MindMed kicks off early stage trial for LSD-MDMA cocktail

MindMed (MMEDF) starts an early stage trial to test the effects of combining psychedelic substance LSD and party drug MDMA in an effort to reduce the negative emotions and anxiety that are sometimes associated with LSD when used in therapy or clinical settings.MindMed aims to understanding how to balance both MDMA and LSD in a cohesive way to create better patient outcomes, and develop more advanced psychedelic assisted therapies.The study is expected to take about one year to complete.The Phase 1 double-blind, placebo-controlled, 4-period crossover design study will assess subjective and autonomic effects aiming to determine the qualitative emotional differences between a combined MDMA and LSD experience, a pure LSD experience and a pure MDMA experience, versus a placebo.

For further details see:

MindMed kicks off early stage trial for LSD-MDMA cocktail